德国生物技术公司 BioNTech SE 今日盘中股价出现大涨,上涨5.21%。
作为开发新冠疫苗"科兴疫苗"并与辉瑞公司达成合作的公司,BioNTech公司在癌症和传染病疫苗方面拥有很强的研发实力。除了继续开发针对新冠的疫苗和药物外,BioNTech 还在推进包括个体化免疫疗法在内的癌症治疗研究。
公司前景看好可能是导致股价上涨的重要原因。分析人士认为,BioNTech 的产品线储备充足,与多家知名制药企业建立了合作关系,未来有望持续取得良好的业绩表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.